Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3390/v13122486

http://scihub22266oqcxt.onion/10.3390/v13122486
suck pdf from google scholar
34960754!8705068!34960754
unlimited free pdf from europmc34960754    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid34960754      Viruses 2021 ; 13 (12): ä
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Heparin and SARS-CoV-2: Multiple Pathophysiological Links #MMPMID34960754
  • Di Micco P; Imbalzano E; Russo V; Attena E; Mandaliti V; Orlando L; Lombardi M; Di Micco G; Camporese G; Annunziata S; Piccinocchi G; Pacelli W; Del Guercio M
  • Viruses 2021[Dec]; 13 (12): ä PMID34960754show ga
  • Low molecular weight heparin, enoxaparin, has been one of most used drugs to fight the SARS-CoV-2 pandemic. Pharmacological properties of heparin recognize its specific ability, as with other oligosaccharides and glycosaminoglycan, to bind several types of viruses during their pass through the extracellular matrix of the respiratory tract, as well as its anticoagulant activity to prevent venous thromboembolism. Antithrombotic actions of enoxaparin have been testified both for inpatients with COVID-19 in regular ward and for inpatients in Intensive Care Units (ICUs). Prophylactic doses seem to be able to prevent venous thromboembolism (VTE) in inpatients in the regular ward, while intermediate or therapeutic doses have been frequently adopted for inpatients with COVID-19 in ICU. On the other hand, although we reported several useful actions of heparin for inpatients with COVID-19, an increased rate of bleeding has been recorded, and it may be related to several conditions such as underlying diseases with increased risks of bleeding, increased doses or prolonged administration of heparin, personal trend to bleed, and so on.
  • |*COVID-19/complications[MESH]
  • |*Heparin[MESH]
  • |*Venous Thromboembolism/etiology/prevention & control[MESH]
  • |Anticoagulants/therapeutic use[MESH]
  • |Enoxaparin[MESH]
  • |Fondaparinux[MESH]
  • |Hemorrhage[MESH]
  • |Heparin, Low-Molecular-Weight[MESH]
  • |Humans[MESH]
  • |Inpatients[MESH]
  • |Intensive Care Units[MESH]
  • |Pandemics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box